These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30400101)

  • 1. Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.
    Bamji-Mirza M; Li Y; Najem D; Liu QY; Walker D; Lue LF; Stupak J; Chan K; Li J; Ghani M; Yang Z; Rogaeva E; Zhang W
    J Alzheimers Dis; 2018; 66(2):853-854. PubMed ID: 30400101
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.
    Bamji-Mirza M; Li Y; Najem D; Liu QY; Walker D; Lue LF; Stupak J; Chan K; Li J; Ghani M; Yang Z; Rogaeva E; Zhang W
    J Alzheimers Dis; 2016 Jun; 53(3):875-92. PubMed ID: 27314524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier.
    Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L
    J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta40 is a major form of beta-amyloid in nonhuman primates.
    Gearing M; Tigges J; Mori H; Mirra SS
    Neurobiol Aging; 1996; 17(6):903-8. PubMed ID: 9363802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology.
    Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease.
    Li M; Yuan Y; Hu B; Wu L
    J Mol Neurosci; 2017 Apr; 61(4):489-497. PubMed ID: 28124230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain.
    Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
    J Alzheimers Dis; 2016 Sep; 54(2):569-84. PubMed ID: 27472885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro.
    Chan SL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye KA; Garner B
    J Neurochem; 2008 Jul; 106(2):793-804. PubMed ID: 18429932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid beta peptides ending at A beta40 and A beta42.
    Fukumoto H; Tomita T; Matsunaga H; Ishibashi Y; Saido TC; Iwatsubo T
    Neuroreport; 1999 Sep; 10(14):2965-9. PubMed ID: 10549806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the function of ABCA7 in Alzheimer's disease.
    Li H; Karl T; Garner B
    Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's disease.
    Jedlitschky G; Vogelgesang S; Kroemer HK
    Clin Pharmacol Ther; 2010 Oct; 88(4):441-3. PubMed ID: 20856238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
    Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
    Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.
    Akanuma S; Ohtsuki S; Doi Y; Tachikawa M; Ito S; Hori S; Asashima T; Hashimoto T; Yamada K; Ueda K; Iwatsubo T; Terasaki T
    Neurochem Int; 2008 May; 52(6):956-61. PubMed ID: 18201804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural product extracts that reduce accumulation of the Alzheimer's amyloid beta peptide: selective reduction in A beta42.
    Yager D; Watson M; Healy B; Eckman EA; Eckman CB
    J Mol Neurosci; 2002; 19(1-2):129-33. PubMed ID: 12212770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta.
    Tai LM; Loughlin AJ; Male DK; Romero IA
    J Cereb Blood Flow Metab; 2009 Jun; 29(6):1079-83. PubMed ID: 19367293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons.
    Kim WS; Chan SL; Hill AF; Guillemin GJ; Garner B
    J Alzheimers Dis; 2009; 16(1):121-31. PubMed ID: 19158428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.